PRO-DEX, INC. Increase (Decrease) in Deferred Charges
PRO-DEX, INC. (PDEX) reported Increase (Decrease) in Deferred Charges of $46.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2026-09-03
- PRO-DEX, INC. increase (decrease) in deferred charges for the quarter ending 2026-06-30 was $30.00K.
- PRO-DEX, INC. increase (decrease) in deferred charges for the quarter ending 2026-03-31 was -$134.00K.
- PRO-DEX, INC. increase (decrease) in deferred charges for the quarter ending 2025-12-31 was $142.00K.
- PRO-DEX, INC. increase (decrease) in deferred charges for the quarter ending 2025-09-30 was $8.00K.
- PRO-DEX, INC. increase (decrease) in deferred charges for fiscal 2026 was $46.00K.
- PRO-DEX, INC. increase (decrease) in deferred charges for fiscal 2025 was -$238.00K.
- PRO-DEX, INC. increase (decrease) in deferred charges for fiscal 2024 was -$232.00K.
- PRO-DEX, INC. increase (decrease) in deferred charges for fiscal 2023 was -$216.00K, a 141.78% decline from fiscal 2022.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2026-06-30 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-03 | -$104.00K derived: sum of 2 quarters · filed 2026-09-03 | $38.00K derived: sum of 3 quarters · filed 2026-09-03 | $46.00K 10-K · filed 2026-09-03 |
| 2026-03-31 | -$134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-30 | $8.00K derived: sum of 2 quarters · filed 2026-04-30 | $16.00K 10-Q · filed 2026-04-30 | -$101.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-12-31 | $142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-29 | $150.00K 10-Q · filed 2026-01-29 | $33.00K derived: sum of 3 quarters · filed 2026-09-03 | $21.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-09-30 | $8.00K 10-Q · filed 2025-10-30 | -$109.00K derived: sum of 2 quarters · filed 2026-09-03 | -$121.00K derived: sum of 3 quarters · filed 2026-09-03 | -$179.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-06-30 | -$117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-03 | -$129.00K derived: sum of 2 quarters · filed 2026-09-03 | -$187.00K derived: sum of 3 quarters · filed 2026-09-03 | -$238.00K 10-K · filed 2026-09-03 |
| 2025-03-31 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-30 | -$70.00K derived: sum of 2 quarters · filed 2026-04-30 | -$121.00K 10-Q · filed 2026-04-30 | -$190.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-29 | -$109.00K 10-Q · filed 2026-01-29 | -$178.00K derived: sum of 3 quarters · filed 2026-01-29 | -$259.00K derived: sum of 4 quarters · filed 2026-01-29 |
| 2024-09-30 | -$51.00K 10-Q · filed 2025-10-30 | -$120.00K derived: sum of 2 quarters · filed 2025-10-30 | -$201.00K derived: sum of 3 quarters · filed 2025-10-30 | -$380.00K derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | -$69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-04 | -$150.00K derived: sum of 2 quarters · filed 2025-09-04 | -$329.00K derived: sum of 3 quarters · filed 2025-09-04 | -$232.00K 10-K · filed 2025-09-04 |
| 2024-03-31 | -$81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-01 | -$260.00K derived: sum of 2 quarters · filed 2025-05-01 | -$163.00K 10-Q · filed 2025-05-01 | $52.00K derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | -$179.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-30 | -$82.00K 10-Q · filed 2025-01-30 | $133.00K derived: sum of 3 quarters · filed 2025-01-30 | -$465.00K derived: sum of 4 quarters · filed 2025-01-30 |
| 2023-09-30 | $97.00K 10-Q · filed 2024-10-31 | $312.00K derived: sum of 2 quarters · filed 2024-10-31 | -$286.00K derived: sum of 3 quarters · filed 2024-10-31 | $4.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-05 | -$383.00K derived: sum of 2 quarters · filed 2024-09-05 | -$93.00K derived: sum of 3 quarters · filed 2024-09-05 | -$216.00K 10-K · filed 2024-09-05 |
| 2023-03-31 | -$598.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-02 | -$308.00K derived: sum of 2 quarters · filed 2024-05-02 | -$431.00K 10-Q · filed 2024-05-02 | -$62.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-08 | $167.00K 10-Q · filed 2024-02-08 | $536.00K derived: sum of 3 quarters · filed 2024-02-08 | $453.00K derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | -$123.00K 10-Q · filed 2023-11-02 | $246.00K derived: sum of 2 quarters · filed 2023-11-02 | $163.00K derived: sum of 3 quarters · filed 2023-11-02 | $403.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-13 | $286.00K derived: sum of 2 quarters · filed 2023-10-13 | $526.00K derived: sum of 3 quarters · filed 2023-10-13 | $517.00K 10-K · filed 2023-10-13 |
| 2022-03-31 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-04 | $157.00K derived: sum of 2 quarters · filed 2023-05-04 | $148.00K 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $240.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-02 | $231.00K 10-Q · filed 2023-02-02 | ||
| 2021-09-30 | -$9.00K 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | $38.00K 10-K · filed 2023-10-13 | |||
| 2020-06-30 | -$275.00K 10-K · filed 2021-09-09 | |||
| 2019-06-30 | $398.00K 10-K · filed 2020-09-10 | |||
| 2018-06-30 | $19.00K 10-K · filed 2019-09-12 | |||
| 2017-06-30 | -$226.00K 10-K · filed 2018-09-13 | |||
| 2016-06-30 | -$615.00K 10-K · filed 2017-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |